Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
0.6044
+0.0184 (3.14%)
At close: Jun 27, 2025, 4:00 PM
0.6001
-0.0043 (-0.71%)
After-hours: Jun 27, 2025, 7:52 PM EDT
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $3.85 million as of June 27, 2025. Its market cap has increased by 126.08% in one year.
Market Cap
3.85M
Enterprise Value
-5.86M
1-Year Change
126.08%
Ranking
Category
Stock Price
$0.60
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $3.85M, a decrease of -93.29%. That is a compound annual growth rate of -50.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 4.43M | 60.69% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.39% |
| Dec 30, 2022 | 4.95M | -65.84% |
| Dec 31, 2021 | 14.49M | -74.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |